SCHEMBL19645693

SCHEMBL19645693

CCC#CC1CCNCC1

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.31
GBA1 P04062 1/20 0.31
GNAI3 P08754 2/20 0.31
GNAO1 P09471 2/20 0.31
GNAI1 P63096 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17039208 0.86
SCHEMBL17039191 0.82 GBA1 (0.34) GBA1GNAI3GNAO1GNAI1
SCHEMBL5004783 0.82
SCHEMBL8607313 0.77
SCHEMBL6150126 0.76
SCHEMBL27119095 0.76 GBA1 (0.32) GBA1
SCHEMBL17036516 0.76
SCHEMBL8605940 0.75 KCNH2 (0.35) KCNH2
SCHEMBL17039192 0.75
Hydrochloric Acid SCHEMBL23250056 0.74 TDP1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023018648-A1 PHENOL DERIVATIVES FOR USE IN THE MODULATION OF BRM GENENTECH, INC. (US) 2023-02-16 WO disclosed
US-9828396-B2 Alkyne compounds for treatment of complement mediated disorders ACHILLION PHARMACEUTICALS, INC. (US) 2017-11-28 US disclosed